Hazardous Drug Compounding Seminar
This application-based program is designed to take factual information presented in published USP, OSHA, NIOSH, and other healthcare guidelines and provide practical and applicable solutions to achieving compliance and safety within your practice.
Frequently Bought Together
COURSE DESCRIPTION
It is imperative that pharmacists are up to date with the latest regulatory and best practice requirements/changes when using hazardous drugs for compounded preparations.
This 1.5-day (12 h) live virtual seminar:
- Provides practical and applicable solutions to help you achieve compliance and safety, sourcing USP, OSHA, NIOSH, and other healthcare guidelines for all areas of practice*
- Offers the opportunity to develop and optimize your own facility blueprints
- Identifies exposure risk and how to correct it through applicable, real-life scenarios
- Facilitates the transition into compliance/maintaining compliance with USP <800>
- Enables eligibility to claim CPE credit (1.2 CEUs)
Earn more CPE credits immediately after this seminar!
- An additional 4-h seminar designed to further enhance your knowledge on current regulations and compliance
- Earn 0.4 CEUs
- Click herefor more information and to register
* Personnel training & competency, PPE, drug handling, compounding processes, cleaning & deactivation, closed-system transfer devices, engineering controls, storage, and more
INTENDED AUDIENCE
Pharmacists, pharmacy technicians, pharmacy managers, quality assurance officers, and compliance specialists looking for practical and applicable solutions to achieve compliance with USP General Chapter <800> Hazardous Drugs – Handling in Healthcare Settings.
LEARNING OBJECTIVES
PHARMACISTS
- Describe the hazardous compounding regulatory framework and standards of practice, including OSHA, NIOSH and USP <800>.
- Examine the risks of working with hazardous drugs in the pharmacy and healthcare continuum.
- Construct a pharmacy-specific hazardous drug list by assessing the occupational risks associated with hazardous drugs.
- Evaluate the critical strategies required to protect personnel, patients, and the environment when handling hazardous drugs in a healthcare setting.
- Assess hazard communication and training requirements.
- Contrast containment primary engineering controls (C-PECs) and their application.
- Interpret facility design plans for non-sterile and sterile hazardous drug compounding.
- Manage safe handling practices required for hazardous drug handling and compounding.
- Evaluate deactivation and decontamination procedures.
- Select personal protective equipment based on the NIOSH tiered approach.
- Demonstrate donning and doffing procedures.
- Examine the advantages of medical surveillance and environmental monitoring.
PHARMACY TECHNICIANS
- Describe the hazardous compounding regulatory framework and standards of practice, including OSHA, NIOSH and USP <800>.
- List the risks of working with hazardous drugs in the pharmacy and healthcare continuum.
- Construct a pharmacy-specific hazardous drug list by assessing the occupational risks associated with hazardous drugs.
- Outline strategies required to protect personnel, patients, and the environment when handling hazardous drugs in a healthcare setting.
- Recognize the importance of hazard communication and training requirements.
- Describe the different containment primary engineering controls (C-PECs) and their rationale for use.
- Reproduce facility design plans for non-sterile and sterile hazardous drug compounding.
- Outline safe handling practices required for hazardous drug handling and compounding.
- Describe deactivation and decontamination procedures.
- Select personal protective equipment based on the NIOSH tiered approach.
- Demonstrate donning and doffing procedures.
- List the advantages of medical surveillance and environmental monitoring.
TESTIMONIALS
"The instructor has a lot of experience and is very enthusiastic, making the course very enjoyable. I definitely recommend this seminar to my peers. It taught me the skills to develop my practice and I am already applying what I learned!”
Ana Gonzalez | Pharmacist
FINANCIAL SUPPORT
This learning activity has received financial support from MEDISCA Inc. in the form of an educational grant.
COPYRIGHT
This CE Activity is Copyright © 2016-2024 LP3 Network.
COURSE DESCRIPTION
It is imperative that pharmacists are up to date with the latest regulatory and best practice requirements/changes when using hazardous drugs for compounded preparations.
This 1.5-day (12 h) live virtual seminar:
- Provides practical and applicable solutions to help you achieve compliance and safety, sourcing USP, OSHA, NIOSH, and other healthcare guidelines for all areas of practice*
- Offers the opportunity to develop and optimize your own facility blueprints
- Identifies exposure risk and how to correct it through applicable, real-life scenarios
- Facilitates the transition into compliance/maintaining compliance with USP <800>
- Enables eligibility to claim CPE credit (1.2 CEUs)
Earn more CPE credits immediately after this seminar!
- An additional 4-h seminar designed to further enhance your knowledge on current regulations and compliance
- Earn 0.4 CEUs
- Click herefor more information and to register
* Personnel training & competency, PPE, drug handling, compounding processes, cleaning & deactivation, closed-system transfer devices, engineering controls, storage, and more
INTENDED AUDIENCE
Pharmacists, pharmacy technicians, pharmacy managers, quality assurance officers, and compliance specialists looking for practical and applicable solutions to achieve compliance with USP General Chapter <800> Hazardous Drugs – Handling in Healthcare Settings.
LEARNING OBJECTIVES
PHARMACISTS
- Describe the hazardous compounding regulatory framework and standards of practice, including OSHA, NIOSH and USP <800>.
- Examine the risks of working with hazardous drugs in the pharmacy and healthcare continuum.
- Construct a pharmacy-specific hazardous drug list by assessing the occupational risks associated with hazardous drugs.
- Evaluate the critical strategies required to protect personnel, patients, and the environment when handling hazardous drugs in a healthcare setting.
- Assess hazard communication and training requirements.
- Contrast containment primary engineering controls (C-PECs) and their application.
- Interpret facility design plans for non-sterile and sterile hazardous drug compounding.
- Manage safe handling practices required for hazardous drug handling and compounding.
- Evaluate deactivation and decontamination procedures.
- Select personal protective equipment based on the NIOSH tiered approach.
- Demonstrate donning and doffing procedures.
- Examine the advantages of medical surveillance and environmental monitoring.
PHARMACY TECHNICIANS
- Describe the hazardous compounding regulatory framework and standards of practice, including OSHA, NIOSH and USP <800>.
- List the risks of working with hazardous drugs in the pharmacy and healthcare continuum.
- Construct a pharmacy-specific hazardous drug list by assessing the occupational risks associated with hazardous drugs.
- Outline strategies required to protect personnel, patients, and the environment when handling hazardous drugs in a healthcare setting.
- Recognize the importance of hazard communication and training requirements.
- Describe the different containment primary engineering controls (C-PECs) and their rationale for use.
- Reproduce facility design plans for non-sterile and sterile hazardous drug compounding.
- Outline safe handling practices required for hazardous drug handling and compounding.
- Describe deactivation and decontamination procedures.
- Select personal protective equipment based on the NIOSH tiered approach.
- Demonstrate donning and doffing procedures.
- List the advantages of medical surveillance and environmental monitoring.
TESTIMONIALS
"The instructor has a lot of experience and is very enthusiastic, making the course very enjoyable. I definitely recommend this seminar to my peers. It taught me the skills to develop my practice and I am already applying what I learned!”
Ana Gonzalez | Pharmacist
FINANCIAL SUPPORT
This learning activity has received financial support from MEDISCA Inc. in the form of an educational grant.
COPYRIGHT
This CE Activity is Copyright © 2016-2024 LP3 Network.